IL214401B
Crystalline form of (r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
56 members in 29 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 14940209 | United States of America | P | |
| 2010023122 | United States of America | W |
Members56
| Document | Office | Kind | |
|---|---|---|---|
| CA2751392A1 | Canada | A1 | |
| WO2010091131A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2010227839A1 | United States of America | A1 | |
| AU2010210627A1 | Australia | A1 | |
| SG173497A1 | Singapore | A1 | |
| ECSP11011285A | Ecuador | A | |
| KR20110120311A | Republic of Korea | A | |
| CL2011001855A1 | Chile | A1 | |
| DOP2011000251A | Dominican Republic | A | |
| MX2011008093A | Mexico | A | |
| EP2393808A1 | European Patent Office (EPO) | A1 | |
| CU20110155A7 | Cuba | A7 | |
| MA33092B1 | Morocco | B1 | |
| CN102439006A | China | A | |
| PE20120585A1 | Peru | A1 | |
| JP2012516894A | Japan | A | |
| CO6620071A2 | Colombia | A2 | |
| RU2011136537A | Russian Federation | A | |
| TN2011000381A1 | Tunisia | A1 | |
| US8426389B2 | United States of America | B2 | |
| US2013310343A1 | United States of America | A1 | |
| ZA201106412B | South Africa | B | |
| NZ594408A | New Zealand | A | |
| ZA201306536B | South Africa | B | |
| JP5584705B2 | Japan | B2 | |
| AP2987A | African Regional Intellectual Property Organization (ARIPO) | A | |
| PH12014500092A1 | Philippines | A1 | |
| PH12014500092B1 | Philippines | B1 | |
| SG10201500207QA | Singapore | A | |
| CU24089B1 | Cuba | B1 | |
| NZ620458A | New Zealand | A | |
| MY156354A | Malaysia | A | |
| AU2010210627B2 | Australia | B2 | |
| BRPI1008829A2 | Brazil | A2 | |
| US2016176905A1 | United States of America | A1 | |
| CR20110464A | Costa Rica | A | |
| CA2751392C | Canada | C | |
| NZ712289A | New Zealand | A | |
| KR20170040371A | Republic of Korea | A | |
| US9624250B2 | United States of America | B2 | |
| UA114068C2 | Ukraine | C2 | |
| KR101739923B1 | Republic of Korea | B1 | |
| CN107082790A | China | A | |
| US2017275315A1 | United States of America | A1 | |
| KR20170135984A | Republic of Korea | A | |
| RU2655928C1 | Russian Federation | C1 | |
| US9988406B2 | United States of America | B2 | |
| US2018244704A1 | United States of America | A1 | |
| US10065947B1 | United States of America | B1 | |
| US2018251482A1 | United States of America | A1 | |
| KR101918678B1 | Republic of Korea | B1 | |
| EP2393808B1 | European Patent Office (EPO) | B1 | |
| US10442829B2 | United States of America | B2 | |
| ES2734724T3 | Spain | T3 | |
| MX2020011773A | Mexico | A | |
| IL214401BThis record | Israel | B |
Numbers
- Publication
- 214401
- Application
- 214401
Titles2
- English
- Crystalline form of (r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
- Hebrew
- צורה גבישית של (r)–3–(4–(2–(2–מתילטטראזול–5–יל)פירידין–5–יל)–3–פלואורופניל)–5–הידרוקסימתיל אוקסאזולידין–2–און דיהידרוגן פוספאט
Classification
- CPC, 8
- C07F9/65583
- A61K31/675
- C07D413/14
- A61P31/04
- A61K31/683
- C07D471/14
- C07F9/06
- C07F9/09